ecancermedicalscience

Case Report

Low-dose “metronomic chemotherapy” with oral cyclophosphamide and methotrexate in metastatic breast cancer: a case report of extraordinarily prolonged clinical benefit

18 Oct 2012
G Masci, A Losurdo, C Gandini, I Garassino, L di Tommaso, R Torrisi, M Zuradelli, A Santoro

We report the case of a 34-year-old woman affected by breast cancer that had metastasized to the bone. She had been treated with oral cyclophosphamide and methotrexate (metronomic chemotherapy) and achieved 3.5 years of clinical remission. To our knowledge, this is the first description of such a prolonged response to therapy. This case report adds weight to known data on metronomic treatment and supports further investigation of this therapy.

Related Articles

Sandy Minck, Gerda Evans, Marie Lowe, Cindy Schultz-Ferguson, Catherine Woulfe, Kym Berchtenbreiter, Krysty Sullivan, Ann White, Lynette Moore, Susan Jarvis, Wendy V Ingman, Jennifer Stone
Abeir El-Mogassabi, Heithum Saleh Baiu, Nadin Omer Hassan, Enas Mohamed Salem, Lugien Elshakmak, Khalil A K Tamoos, Mohammed Zidan, Asma Rajab Ben Rashid, Ala Elhoudiri, Sama Elmehdawi, Dania Shareia
Md Foorquan Hashmi, Fiza Khan, Elen Baloyan, Liana Safaryan, Davit Zohrabyan, Gevorg Tamamyan, Samvel Bardakhchyan
Gabriel Berlingieri Polho, Leticia Kimie Murazawa, Vinicius Vitor Oliveira, Victor Rocha Pinheiro, Diana del Cisne Pineda Labanda, Yumi Ricucci Shinkado, Romualdo Barroso-Sousa, Luciana Rodrigues Carvalho Barros, Laura Testa, Renata Colombo Bonadio
Tooba Ali, Nasir Ali, Syed Aun Hasan, Nawazish Zehra, Laraib Khan, Maham Khan, Mariam Hina, Bilal Ahmed, Fabiha Shakeel, Ahmed Nadeem Abbasi, Bilal Mazhar Qureshi, Asim Hafiz, Maria Tariq, Sehrish Abrar